© 2019 The Sonder Group

Hiring in Q3 continues to be strong in the life science market.  Hear are some of the roles available thru the Sonder Group.  Reach out to learn more, share with a friend or meet up with me at Boston Biotech week.

Vice President, Oncology Diagnostics Commercialization (Boston or Baltimore)

New Molecular diagnostics company founded by leaders at Johns Hopkins Medical School seek a commercial strategy leader to oversee the development & execution of a launch plan for the cancer diagnostics business including sales, marketing and...

From January to April 2017, we have seen promising financial indicators for both private and public life science companies.  On the venture side, Twist Biosciences announced a $33M raise which brings it to a total of $166M to date.  Cash can be a significant competitive advantage when building a company in highly transformative markets, like Synthetic biology, and Gene editing (e.g., using CRISPR).   Just last week, Two Pore Guys, a new company that has developed a hand-held nanopore sensor raised $24.5 M in a Series A round...

So far, the first quarter of 2017 is looking good for NewCo life science platform companies in Boston.  908 Devices, a Boston based pioneer of small and elegantly systems for chemical and biomolecule analysis, announced a sales partnership with Thermo Fisher to sell their ZipChip™ as a front-end to Thermo’s mass spectrometry (MS) instruments. They followed that up by closing a $20M growth equity round in March. RedShift BioAnalytics, based in Burlington, MA, completed a Series C raise of $11M with strategic investments from Water...

Are you interested in monitoring the US venture capital funding in our sector?  Look no further than PwC’s MoneyTree report. The company offers a quarterly report that breaks down deals by quarter, stages and venture capital outlook for the life science sector. The most recent report, Q316, indicates that venture capitalists invested $2.5 billion in 156 life science companies during the third quarter which was down from $3.0 billion in 210 deals during the same quarter of 2015. The silver lining was that the average deal size increase...

Please reload

Categories
Follow Us
  • LinkedIn Social Icon
  • Twitter Basic Square
  • Facebook Social Icon